CME (CME) | Stock Overview & Key Data
CME Performance Comparison
Stock Range
Today's Range
Low: $269.50
High: $272.75
on August 19, 2025
52 Week Range
Low: $206.44
High: $290.79
on August 23, 2024
on June 2, 2025
All-Time High: $290.79 on June 2, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$98.7B
EPS
10.33
P/E Ratio (TTM)
26.52
Forward P/E
26.41
P/B Ratio
3.55
PEG Ratio
1.70
Div. Yield
4.30%
ROE
13.61%
Beta
0.457
Debt to Equity
13.60
Financial Highlights
Profitability
Gross Margin
86.90%
Operating Margin
66.87%
Profit Margin
58.59%
Returns and Earnings
Return on Assets (TTM)
1.74%
Return on Equity (TTM)
13.61%
EBITDA
$960.0M
Net Income (TTM)
$3.7B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$17.89
Quarterly Revenue Growth (YoY)
10.40%
Quarterly Earnings Growth (YoY)
16.10%
Dividend Information
Last 12-Month Dividend
$11.85
Current Dividend Yield
4.30%
3-Year Average Dividend Yield
0.91%
3-Year Average Annual Dividend
$10.10
3-Year Total Dividends
$30.30
Ex-Dividend Date
September 9, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| CME CME | 98.72B Large-cap | -1.59% | -1.28% | -2.32% | 8.27% | 16.66% | 31.12% | 38.27% | 53.36% |
| S&P Global SPGI | 169.89B Large-cap | -0.83% | 6.19% | 5.75% | 2.16% | 11.89% | 10.76% | 52.29% | 51.14% |
| Intercontinental ICE | 101.86B Large-cap | -2.45% | -1.40% | 0.86% | 6.77% | 19.37% | 11.41% | 72.09% | 68.88% |
| Moody's MCO | 91.36B Large-cap | -0.78% | 2.37% | 4.04% | -1.40% | 8.28% | 6.80% | 74.80% | 73.92% |
| Coinbase Global COIN | 80.51B Large-cap | -6.37% | -26.97% | 14.42% | 16.78% | 17.44% | 42.89% | 352.61% | -11.68% |
| Nasdaq NDAQ | 54.33B Large-cap | -2.39% | 5.14% | 14.48% | 13.61% | 21.18% | 33.38% | 54.61% | 113.49% |
Ownership & Short Interest
Insider Ownership
0.45%
Institutional Ownership
91.81%
Shares Short
5M
Short Ratio
2.53
Short % of Shares Outstanding
1.51%
Average 10-Day Volume
2M
Average 90-Day Volume
2M
CME Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in CME would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CME's 52-week high and low?
- In the last 52 weeks, CME reached a high of $290.79 (on June 2, 2025) and a low of $206.44 (on August 23, 2024).
- What is the market cap and P/E ratio for CME?
- Curious about CME's size and valuation? Its market capitalization stands at 98.72B. When it comes to valuation, the P/E ratio (trailing twelve months) is 26.52, and the forward P/E (looking ahead) is 26.41.
- Does CME pay dividends? If so, what's the yield?
- Yes, CME is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 4.30%, and the company has paid an average of $10.10 per share annually over the past 3 years.
- Who are CME's main competitors or similar companies to consider before investing?
When looking at CME, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return S&P Global
SPGI169.89B Financial Services Financial Data & Stock Exchanges 10.76% 52.29% Intercontinental
ICE101.86B Financial Services Financial Data & Stock Exchanges 11.41% 72.09% Moody's
MCO91.36B Financial Services Financial Data & Stock Exchanges 6.80% 74.80% Coinbase Global
COIN80.51B Financial Services Financial Data & Stock Exchanges 42.89% 352.61% Nasdaq
NDAQ54.33B Financial Services Financial Data & Stock Exchanges 33.38% 54.61% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for CME Group Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of CME's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 13.61%, the Debt to Equity ratio from the most recent quarter is 13.60, and its Gross Profit Margin stands at 86.90%.
- What is the recent revenue and earnings growth for CME?
- Looking at CME's growth, its revenue over the trailing twelve months (TTM) was $6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.40%, and quarterly earnings saw a YoY growth of 16.10%.
- How much of CME stock is held by insiders and institutions?
- Wondering who owns CME stock? Company insiders (like executives and directors) hold about 0.45% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 91.81%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.